CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 46 enrolled
Drug / intervention
Clarithromycin +3 moredrug
Likely dose
Clarithromycin 500mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02969928
NCT02969928Phase 3Completed
CompareCT.gov

Full-mouth Periodontal Debridement Associated With Two Different Antibiotic Agents to Treat Generalized Aggressive Periodontitis: Randomized Controlled Clinical Trial

Universidade Estadual Paulista Júlio de Mesquita Filho·interventional·Posted Nov 21, 2016·Updated Dec 28, 2021

In Brief

A Phase 3 clinical trial evaluating Full-mouth ultrasonic debridement, Clarithromycin, and 2 other interventions for Aggressive Periodontitis. Completed, enrolled 46 participants across 1 site.

Detailed Summary

The aim of this study is to assess the clinical outcomes of full-mouth ultrasonic debridement combined with clarithromycin or amoxicillin + metronidazole association for the treatment of generalized aggressive periodontitis (GAgP).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAggressive Periodontitis
CountriesBrazil
Collaborators--

Timeline

Phase 3CompletedFinished
201520162017201820192020202120222023202420252026
First PostedNov 21, 2016
Enrollment StartMar 1, 2015
Primary CompletionDec 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 9.6 years ago

Interventions

Full-mouth ultrasonic debridementprocedure

Full-mouth ultrasonic debridement will be performed in order to treat diseased sites

Clarithromycindrug

Administration of Clarithromycin 500mg bid for 7 days

Amoxicillindrug

Administration of Amoxicillin 500mg tid for 7 days.

Metronidazoledrug

Administration of Metronidazole 400mg tid for 7 days.